# Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

> **NCT01341912** · PHASE3 · COMPLETED · sponsor: **Octapharma** · enrollment: 3 (actual)

## Conditions studied

- Severe Hemophilia A

## Interventions

- **BIOLOGICAL:** Human-cl rhFVIII

## Key facts

- **NCT ID:** NCT01341912
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341912, "Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01341912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*